Terms: = Ovarian cancer AND TCF7L2, ENSG00000148737, 6934, TCF-4
12 results:
1. Advanced stage, high-grade primary tumor ovarian cancer: a multi-omics dissection and biomarker prediction process.
Honar YS; Javaher S; Soleimani M; Zarebkohan A; Farhadihosseinabadi B; Tohidfar M; Abdollahpour-Alitappeh M
Sci Rep; 2023 Oct; 13(1):17265. PubMed ID: 37828118
[TBL] [Abstract] [Full Text] [Related]
2. Next-generation sequencing shows the genomic features of ovarian clear cell cancer and compares the genetic architectures of high-grade serous ovarian cancer and clear cell carcinoma in ovarian and endometrial tissues.
Gan M; Tai Z; Yu Y; Zhang C; Xu J
PeerJ; 2023; 11():e14653. PubMed ID: 36721777
[TBL] [Abstract] [Full Text] [Related]
3. The Wnt3a/β-catenin/tcf7l2 signaling axis reduces the sensitivity of HER2-positive epithelial ovarian cancer to trastuzumab.
Shen G; Gao Q; Liu F; Zhang Y; Dai M; Zhao T; Cheng M; Xu T; Jin P; Yin W; Huang D; Weng H; Chen W; Ren H; Mu X; Wu X; Hu S
Biochem Biophys Res Commun; 2020 Jun; 526(3):685-691. PubMed ID: 32248976
[TBL] [Abstract] [Full Text] [Related]
4. Vitamin D Suppresses ovarian cancer Growth and Invasion by Targeting Long Non-Coding RNA CCAT2.
Wang L; Zhou S; Guo B
Int J Mol Sci; 2020 Mar; 21(7):. PubMed ID: 32230936
[TBL] [Abstract] [Full Text] [Related]
5. EGFL6 promotes cell proliferation in colorectal cancer via regulation of the WNT/β-catenin pathway.
Zhang QW; Zhang XT; Tang CT; Lin XL; Ge ZZ; Li XB
Mol Carcinog; 2019 Jun; 58(6):967-979. PubMed ID: 30693973
[TBL] [Abstract] [Full Text] [Related]
6. Personalized Medicine-Based Approach to Model Patterns of Chemoresistance and Tumor Recurrence Using ovarian cancer Stem Cell Spheroids.
Raghavan S; Mehta P; Ward MR; Bregenzer ME; Fleck EMA; Tan L; McLean K; Buckanovich RJ; Mehta G
Clin Cancer Res; 2017 Nov; 23(22):6934-6945. PubMed ID: 28814433
[No Abstract] [Full Text] [Related]
7. Association of genetic susceptibility variants for type 2 diabetes with breast cancer risk in women of European ancestry.
Zhao Z; Wen W; Michailidou K; Bolla MK; Wang Q; Zhang B; Long J; Shu XO; Schmidt MK; Milne RL; García-Closas M; Chang-Claude J; Lindstrom S; Bojesen SE; Ahsan H; Aittomäki K; Andrulis IL; Anton-Culver H; Arndt V; Beckmann MW; Beeghly-Fadiel A; Benitez J; Blomqvist C; Bogdanova NV; Børresen-Dale AL; Brand J; Brauch H; Brenner H; Burwinkel B; Cai Q; Casey G; Chenevix-Trench G; Couch FJ; Cox A; Cross SS; Czene K; Dörk T; Dumont M; Fasching PA; Figueroa J; Flesch-Janys D; Fletcher O; Flyger H; Fostira F; Gammon M; Giles GG; Guénel P; Haiman CA; Hamann U; Harrington P; Hartman M; Hooning MJ; Hopper JL; Jakubowska A; Jasmine F; John EM; Johnson N; Kabisch M; Khan S; Kibriya M; Knight JA; Kosma VM; Kriege M; Kristensen V; Le Marchand L; Lee E; Li J; Lindblom A; Lophatananon A; Luben R; Lubinski J; Malone KE; Mannermaa A; Manoukian S; Margolin S; Marme F; McLean C; Meijers-Heijboer H; Meindl A; Miao H; Muir K; Neuhausen SL; Nevanlinna H; Neven P; Olson JE; Perkins B; Peterlongo P; Phillips KA; Pylkäs K; Rudolph A; Santella R; Sawyer EJ; Schmutzler RK; Schoemaker M; Shah M; Shrubsole M; Southey MC; Swerdlow AJ; Toland AE; Tomlinson I; Torres D; Truong T; Ursin G; Van Der Luijt RB; Verhoef S; Wang-Gohrke S; Whittemore AS; Winqvist R; Pilar Zamora M; Zhao H; Dunning AM; Simard J; Hall P; Kraft P; Pharoah P; Hunter D; Easton DF; Zheng W
Cancer Causes Control; 2016 May; 27(5):679-93. PubMed ID: 27053251
[TBL] [Abstract] [Full Text] [Related]
8. MiR-1207 overexpression promotes cancer stem cell-like traits in ovarian cancer by activating the Wnt/β-catenin signaling pathway.
Wu G; Liu A; Zhu J; Lei F; Wu S; Zhang X; Ye L; Cao L; He S
Oncotarget; 2015 Oct; 6(30):28882-94. PubMed ID: 26337084
[TBL] [Abstract] [Full Text] [Related]
9. Association between tcf7l2 gene polymorphism and cancer risk: a meta-analysis.
Chen J; Yuan T; Liu M; Chen P
PLoS One; 2013; 8(8):e71730. PubMed ID: 23951231
[TBL] [Abstract] [Full Text] [Related]
10. SPINDLIN1 promotes cancer cell proliferation through activation of WNT/tcf-4 signaling.
Wang JX; Zeng Q; Chen L; Du JC; Yan XL; Yuan HF; Zhai C; Zhou JN; Jia YL; Yue W; Pei XT
Mol Cancer Res; 2012 Mar; 10(3):326-35. PubMed ID: 22258766
[TBL] [Abstract] [Full Text] [Related]
11. Integrin regulation of beta-catenin signaling in ovarian carcinoma.
Burkhalter RJ; Symowicz J; Hudson LG; Gottardi CJ; Stack MS
J Biol Chem; 2011 Jul; 286(26):23467-75. PubMed ID: 21518759
[TBL] [Abstract] [Full Text] [Related]
12. No association between a candidate tcf7l2 variant and risk of breast or ovarian cancer.
Goode EL; Szabo C; Prokunina-Olsson L; Vierkant RA; Fredericksen ZS; Collins FS; White KL; Schmidt M; Fridley BL; Couch FJ
BMC Cancer; 2009 Sep; 9():312. PubMed ID: 19732438
[TBL] [Abstract] [Full Text] [Related]
